Viewing Protocol Section

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT00112502
Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00112502
Protocol Section: NCT00112502
Start Identification Module Data
Expand Identification Module Data
Brief Title: Temozolomide Alone or in Combination With Thalidomide andor Isotretinoin andor Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
Official Title: A Randomized Factorial-Design Phase II Trial of Temozolomide Alone and in Combination With Possible Permutations of Thalidomide Isotretinoin andor Celecoxib as Post-Radiation Adjuvant Therapy of Glioblastoma Multiforme
Acronym: None
Organization: MD Anderson Cancer Center
Organization Class: OTHER
Organization Study ID: 2004-0662
Secondary IDs
Secondary ID Type Domain Link
MDA-ID-02586 None None None
NCI-6636 None None None
MDA-2004-0662 None None None
CDR0000432954 OTHER None None
NCI-2009-00076 REGISTRY NCI CTRP None
Start Status Module Data
Status Verified Date: 2021-09
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: MD Anderson Cancer Center
Lead Sponsor Class: OTHER
Lead Sponsor: MD Anderson Cancer Center
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload